A recent study focuses on the intersection of these two scientific puzzles, resulting in new discoveries about how one herpes virus known to cause cancer may reactivate when the infected cell senses another type of virus entering it.
Effective drugs for treating a chemotherapy-resistant form of Lymphoma might already be on the market according to a study that has pieced together a chemical pathway involved in the disease. By following the trail of several molecular flags that mark this type of cancer, researchers have discovered that anti-inflammatory drugs used to treat arthritis will shrink Lymphoma tumors in mice.
Patients treated for Hodgkin Lymphoma with radiation therapy have a substantially higher risk of stroke, according to a new study.
Scientists have identified a stromal marker for breast cancer progression.
Research has shown for the first time how cancers that spread to the brain establish themselves and begin to grow.
Scientists have uncovered clues to the development of cancers in AIDS patients.
Researchers have identified a key mechanism that causes chromosomes within blood cells to break — an occurrence that marks the first step in the development of human Lymphoma.
Seeking ways to improve blood recovery after chemotherapy or bone marrow transplant, researchers have discovered that fat cells, which accumulate in bone marrow as people age, inhibit the marrow’s ability to produce new blood cells. Their study suggests that blocking this fatty infiltration could help enhance patients’ recovery after transplant.
Investigators have discovered that a waste disposal protein is the key to cancer tumor suppression in a process known as autophagy — a process in which cancer cells eat themselves.
A single gene can control growth in cancers related to the Epstein-Barr virus and that existing therapeutics can inactivate it, according to new research.
